Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Redox modulation of chemotherapy-induced tumor cell killing and normal tissue toxicity.

× No keyword cloud information.

16 in total

1. First clinical experience with the magnetic resonance imaging contrast agent and superoxide dismutase mimetic mangafodipir as an adjunct in cancer chemotherapy-a translational study.

Authors: Jan Olof G Karlsson; Karin Adolfsson; Bo Thelin; Per Jynge; Rolf Gg Andersson; Ursula G Falkmer
Journal: Transl Oncol Date: 2012-02-01 Impact factor: 4.243

2. Effects of MnDPDP and ICRF-187 on Doxorubicin-Induced Cardiotoxicity and Anticancer Activity.

Authors: Tino Kurz; Derek Grant; Rolf Gg Andersson; Robertson Towart; Michelandrea De Cesare; Jan Olof G Karlsson
Journal: Transl Oncol Date: 2012-08-01 Impact factor: 4.243

3. Individual responses to chemotherapy-induced oxidative stress.

Authors: Dora Il'yasova; Kelly Kennedy; Ivan Spasojevic; Frances Wang; Adviye A Tolun; Karel Base; Sarah P Young; P Kelly Marcom; Jeffrey Marks; David S Millington; Mark W Dewhirst
Journal: Breast Cancer Res Treat Date: 2010-09-10 Impact factor: 4.872

4. Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells.

Authors: Gang Cheng; Marcos Lopez; Jacek Zielonka; Andrew D Hauser; Joy Joseph; Donna McAllister; J Jordi Rowe; Sonia L Sugg; Carol L Williams; Balaraman Kalyanaraman
Journal: Cancer Biol Ther Date: 2011-10-15 Impact factor: 4.742

5. Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines.

Authors: Laetitia Dahan; Amine Sadok; Jean-Louis Formento; Jean François Seitz; Hervé Kovacic
Journal: Br J Pharmacol Date: 2009-09 Impact factor: 8.739

6. Superior therapeutic index of calmangafodipir in comparison to mangafodipir as a chemotherapy adjunct.

Authors: Jan Olof G Karlsson; Tino Kurz; Susanne Flechsig; Jacques Näsström; Rolf Gg Andersson
Journal: Transl Oncol Date: 2012-12-01 Impact factor: 4.243

7. ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage.

Authors: Xiaohua Peng; Varsha Gandhi
Journal: Ther Deliv Date: 2012-07

8. Investigational cancer drugs targeting cell metabolism in clinical development.

Authors: Douglas W Sborov; Bradley M Haverkos; Pamela J Harris
Journal: Expert Opin Investig Drugs Date: 2014-09-16 Impact factor: 6.206

9. High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial.

Authors: L John Hoffer; Line Robitaille; Robert Zakarian; David Melnychuk; Petr Kavan; Jason Agulnik; Victor Cohen; David Small; Wilson H Miller
Journal: PLoS One Date: 2015-04-07 Impact factor: 3.240

10. Mitochondrial adaptations to oxidative stress confer resistance to apoptosis in lymphoma cells.

Authors: Sarah T Wilkinson; Margaret E Tome; Margaret M Briehl
Journal: Int J Mol Sci Date: 2012-08-16 Impact factor: 6.208